Close Menu

NEW YORK – Diagnostics developer Scope Fluidics has secured €6.2 million in new funding to advance its molecular diagnostic system, PCR One, it said on Monday.

Specifically, Scope Fluidics has raised €4.5 million ($5.3 million) from the sale of 127,915 offered shares, and obtained €1.7 million from the National Centre for Research and Development in Poland for its subsidiary Curiosity Diagnostics, which is developing the PCR One system.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.